Whereas it is well known that T3 inhibits TSH␤ gene transcription, its effects on TSH␤ mRNA stability and translation have been poorly investigated. This study examined these possibilities, by evaluating the TSH␤ transcripts poly(A) tail length, translational rate and binding to cytoskeleton, in pituitaries of thyroidectomized and sham-operated rats treated with T3 or saline, and killed 30 min thereafter. The hypothyroidism induced an increase of TSH␤ transcript poly(A) tail, as well as of its content in ribosomes and attachment to cytoskeleton. The hypothyroid rats acutely treated with T3 exhibited a reduction of TSH␤ mRNA poly(A) tail length and recruitment to ribosomes, indicating that this treatment decreased the stability and translation rate of TSH␤ mRNA. Nevertheless, acute T3 administration to sham-operated rats provoked an increase of TSH␤ transcripts binding to ribosomes. These data add new insight to an important role of T3 in rapidly regulating TSH gene expression at posttranscriptional level.
Introduction
Thyroid hormones (THs) act at the transcriptional level to regulate gene expression. Most of THs response genes are positively (Ishiguro et al., 2010; Calvo and Obregon, 2009 ), while few are negatively regulated by T3. TSH gene is one of THs down-regulated genes, and its expression has been shown to be controlled by T3 at the transcriptional and posttranscriptional levels (Yusta et al., 1998; Staton and Leedman, 1998) , being the latter poorly explored. Usually, the posttranscriptional actions do not depend on THs binding to the nuclear receptors (TRs), are achieved in a short period of time, and occur even in the presence of drugs that block gene transcription, which point out to a non-genomic action of THs (Siegrist-Kaiser et al., 1990) .
In fact, some binding sites for THs have been identified at the cytosol, plasma membrane and some organelles, like endoplasmic reticulum and mitochondria (Cao et al., 2009; Verga Falzacappa et al., 2009; Davis et al., 2005 Davis et al., , 2009 Cheng et al., 1987; Psarra et al., 2006) , and were shown to be involved in the rapid actions of THs, including those on the mRNA processing. Indeed, some pituitary transcripts have their stability modulated by THs, as GH and TSH, whose half-lives increase and decrease after T3 treatment, respectively (Diamond and Goodman, 1985; Krane et al., 1991) .
The posttranscriptional modulation of gene expression requires proteins which recognize specific sequences at the end of 3 -untranslated region (3 -UTR) of the transcript, making it more or less sensitive to degradation (Nechama et al., 2009) . Other proteins, which are responsible for the transcript poly(A) tail lengthening and integrity (Misquitta et al., 2006) were also shown to be involved with this event.
It is recognized that transcripts with long poly(A) tails are more stable and efficiently translated, and, as a consequence, they can generate more protein. However, this process depends, among other factors, on the transcript poly(A) tail association to translational factors, and of its arrestment to the ribosomal subunits (Algire and Lorsch, 2006; Kimball et al., 1999; Stipanuk, 2007) , process in which the cytoskeleton plays a key role.
It is known that the association of the transcripts to cytoskeleton depends on specific proteins, like the elongation factor of polypeptide chain 1A (EF1A) (Liu et al., 2002) . This process confers stability to the transcripts, and also allows them to be transported to different regions of the cells, where they can be translated (Mohr and Richter, 2004; Shestakova et al., 1993a,b) .
Indeed, GH transcripts have their stability and translational rate rapidly increased in parallel to cytoskeleton rearrangement, in rats acutely treated with T3 (da Silva et al., 2006 Silva et al., , 2010 . Moreover, GH gene expression is positively regulated by thyroid hormone at both the transcriptional and posttranscriptional level.
Taking into account that TSH is the most important regulator of thyroid function, and that the gene that encodes TSH␤ is down-regulated by T3 at the transcriptional level, we attempted to investigate whether T3 could rapidly act on TSH␤ gene expression at the posttranscriptional level, modifying the stability and translation rate of TSH␤ transcripts.
Materials and methods

Materials
T3, methylmercaptoimidazole and Triton X-100 were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Polyvinylidene difluoride filters (PVDF Hybond-P) was purchased from Amersham Biosciences (Piscataway, NJ, USA). Rhodaminephalloidin was purchased from Molecular Probes (Eugene, OR, USA). The commercial kit RIA-gnost T3 was obtained from CIS Bio International (Gif-sur-Yvette, FR). TSH concentrations in serum were measured by chemiluminescence immunoassay using Luminex xMAP technology (LINCOplex kit; Luminex Corp., Austin, TX, USA). BSA, ␤-mercaptoethanol, oligo dT, dNTP, 5× First-Strand buffer, reverse transcriptase (M-MLV) and Random Primers DNA Labeling System kit were purchased from Invitrogen Life Technology (Grand Island, NY, Carlsbad, CA and Gaithersburg, MD, USA). GoTaq ® DNA Polymerase and 5× Green GoTaq ® Flexi Buffer were purchased from Promega (Madison, WI, USA). SYBR ® Green PCR master mix was purchased from Applied Biosystems (Foster City, CA, USA). Maxi Script in vitro transcription kit was purchased from Ambion (Austin, TX, USA). All other reagents were purchased from Labsynth (São Paulo, SP, Brazil).
Animals and treatments
Male Wistar rats weighing 200-250 g were obtained from our own breeding colony and maintained on rat chow and tap water ad libitum. They were housed in a room kept at constant temperature (23 ± 1
• C) and on a 12 h-light, 12-h dark (lights on at 0700 h) schedule. The animals were made hypothyroid by surgical thyroidectomy, after being deeply anesthetized with ketamine and xylazine, and received 0.03% methylmercaptoimidazole (MMI), plus 4.5 mM calcium chloride in drinking water during 20 days. The animals were assorted in two experimental groups, named euthyroid sham-operated (SO) and hypothyroid, which were subjected to acute (30 min) T3 administration (100 g T3 per 100 g BW) (da Silva et al., 2010; Pachucki et al., 1999) or saline. At least three animals per group were used. Rats were weighed and killed by decapitation 30 min after T3 or saline intravenous treatment. The pituitaries were excised and used for the analysis of TSH␤ mRNA poly(A) tail length and translation rate, by rapid amplification of cDNA endspoly(A) test (RACE-PAT) and polysome profile, respectively. The TSH␤ transcripts binding to cytoskeleton was also evaluated. The experimental protocol conformed with the ethical principles in animal research adopted by the Brazilian College of Animal Experimentation and was approved by the Institute of Biomedical Sciences/University of São Paulo-Ethical Committee for Animal Research.
Evaluation of TSHˇmRNA poly(A) tail length
TSH␤ mRNA poly(A) tail length was measured by RACE-PAT, according standard protocol (Sallés et al., 1999; Serrano-Nascimento et al., 2010) . In brief, 200 ng of an oligo(dT) anchor (5 -GCGAGCTCCGCGGCCGCG-T12) were added to 2 g of total RNA in a sterile RNase-free microfuge tube. The samples were denatured at 65
• C for 5 min, transferred to 42
• C and reverse-transcribed for 60 min, using a mix containing: 10 mM of each dNTP, 5× First-Strand buffer, 0.01 M of DTT, 1 l of reverse transcriptase M-MLV Reverse Transcriptase (Invitrogen Life Technology). The inactivation of the reaction was performed at 70
• C for 15 min. Three microliters of the RT reaction product were mixed to a reaction buffer containing 25 mM of MgCl2, 10 mM of each dNTP, 25 pmol of each primer [TSH␤ 5 -CTGCAAGTGTGGCAAGTGTAA-3 and oligo(dT) anchor], 1.25 U of GoTaq ® DNA Polymerase and 5× Green GoTaq ® Flexi Buffer (Promega). The reaction was performed for 40 cycles; each cycle consisted of 95
• C for 30 s (denaturation), 68
• C for 1 min (annealing), and 72
• C for 1 min (extension), followed by a final 7 min elongation step at 72
• C. The PCR-amplified products were submitted to denaturing electrophoretic separation on 2.5% (w/v) agarose gels stained by ethidium bromide. Amplicon sizes were estimated by densitometry and compared with a 100-bp DNA ladder (Invitrogen Life Technologies) using the ImageQuant TL software (Version 2005 Amersham Biosciences). The top of the smear indicated the longest amplified fragment, which represents the poly(A) tail size plus 213 bases upstream, according to the TSH␤ primer used. The changes in poly(A) tail length were detected by analyzing the length of the cDNA smears obtained in all experimental groups studied.
Actin fractionation for the evaluation of TSHˇmRNA bound to F-actin
The protocol was adapted from Posern et al. (2002) , Haller et al. (2004) , and Liu et al. (2002) . In order to evaluate the amount of TSH␤ mRNA bound to F-actin the pituitaries were lysed in 0.3 ml ice lysis buffer containing 50 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 20 mM HEPES (pH 7.9), and phalloidin (132 nM), a fungal toxin that specifically binds to and preserves F-actin from depolymerization (da Silva et al., 2010) . After 10 min, the homogenate was centrifuged at 100,000 × g for 30 min at 4
• C, and the supernatant (non-polymerized actin) and pellet fractions (polymerized actin) were obtained. The pellet, which represents the F-actin fraction, was resuspended in 0.1 ml of actin lysis buffer and sonicated. To investigate the TSH␤ mRNA binding to actin cytoskeleton the transcript was taken out from Factin by guanidine-phenol-chloroform method (Chomczynski and Sacchi, 1987) , and submitted to real-time PCR, as described afterwards. The protocol was adapted from Fourcroy et al. (1981) . A pool of 10 pituitaries was homogenized in 0.6 ml lysis buffer containing 15 mM Tris-HCl (pH 7.4), 25 mM MgCl2, 300 mM NaCl, 1% Triton X-100, 0.1 mg/ml cycloheximide, 1 mM dithiothreitol and 10 mg/ml heparin. After removal of cell debris by centrifugation at 10,000 × g for 10 min at 4
• C, the nucleic acid concentration of supernatant was quantified, and 14 AU (absorbance unit) were loaded onto a 10 ml sucrose gradient (7-47% w/v), and centrifuged at 39,000 rpm for 150 min (SW41 Ti rotor -Beckmann). The UV absorbance of the resulting gradients was monitored at 254 nm (Monitor UVis-920; GE HealthcareBio-Sciences AB, Uppsala, Sweden). The gradients were collected into 11 fractions of approximately 1 ml each for RNA isolation, immediately frozen on dry ice, and then stored at −70
• C. For statistical analysis, fractions 6 through 11 were classified as the polysome region. The first discernible ribosomal subunit peak generally fell in fraction 2 or 3. TSH␤ mRNA bound to ribosome was determined by Northern blot analysis, as follows (da Silva et al., 2010).
Isolation of polysomal RNA
For RNA isolation, 1 ml from each polysomal fraction was mixed with 2 ml guanidine thiocyanate 4 M and 3 ml absolute ethyl alcohol, kept overnight at −70
• C and centrifuged at 10,000 × g for 20 min at 4
• C for RNA precipitation. RNA pellets were washed with 70% ethyl alcohol and dissolved in diethyl pyrocarbonate (DEPC)-treated water, at 65
• C, for 15 min. Then, 2 mM sodium acetate, ethyl alcohol (1:0.5 v/v) and 45 U of heparin were added to the samples, which were centrifuged at 13,000 rpm for 20 min at 4
• C (5415R -Eppendorf). RNA pellets were washed with 70% ethyl alcohol, dried, denatured with formaldehyde and formamide, and loaded onto a 1.0% agarose/formaldehyde gel for Northern blot analysis (da Silva et al., 2010) . This protocol was adapted from Chomczynski and Sacchi (1987) . The RNAs of first fractions of polysomal profile were extracted by guanidine-phenol-chloroform method (Chomczynski and Sacchi, 1987) .
Northern blotting
The RNA samples were blotted from the gel to a Hybond N1 membrane (Amersham) by neutral capillary transfer, and baked at 80
• C for 1 h in a vacuum oven. Blots were then probed with 32 P-labeled rat TSH␤ cDNA by random priming (Random Primers DNA Labeling System kit; Invitrogen Life Technology) for 16 h at 42
• C. The membrane was washed under highly stringent conditions, subjected to autoradiography, and quantified using the Image Master-1D-Pharmacia Biotech SW software. All blots were stripped and re-hybridized with a 32 P-labeled RNA probe specific for 18S ribosomal subunit (18S rRNA), synthesized by in vitro transcription (Maxi Script in vitro transcription kit; Ambion), to correct for the variability in RNA loading. The results were expressed as mean ± SEM of TSH␤ mRNA/18S rRNA ratio.
Real-time PCR
This procedure was used to determine the amount of pituitary TSH␤ mRNA bound to cytoskeleton. Total RNA extracted from pituitary (Chomczynski and Sacchi, 1987) were treated with RNase-free DNase I (Invitrogen Life Technology), and 2 g of RNA were reverse-transcribed in a reaction containing oligo dT (100 g/ml); 10 mM dNTP; 5× First-Strand buffer; 2 l of 200 U M-MLV reverse transcriptase (Invitrogen Life Technology). For real-time PCR amplification, 2 l of each reverse transcription product was diluted in a reaction buffer containing: 5 l SYBR ® Green PCR master mix (Applied Biosystems) and 900 nM primers in a final volume of 10 l per sample. All primers used are listed in Table 1 . The reaction conditions consisted in two steps at 50
• C for 2 min and 95
• C for 10 min, followed by 45 cycles of three steps: 20 s denaturation at 95
• C, 60 s annealing at 58
• C, and 20 s at 72
• C. The threshold cycle (CT) of the real-time RT-PCR was measured in duplicate for each sample, and the threshold was set up at the beginning of the amplification, in the logarithm scale. The CT value represents the PCR cycle number at which the increase fluorescence intensity of amplified RT-PCR products of the target gene is exponential, and correlates inversely to the amount of the target mRNA in the sample. A CT value was calculated for each sample by subtracting the CT value of the gene, treated as the reference gene, from the CT value of the gene of interest. To reduce interassay variation, all samples were normalized to the CT value of a control sample derived from the same control animal, for all assays ( CT). The relative expressions of mRNAs were calculated, using the expression 2-CT, and reported as AU. The endogenous control used was the RPL19 gene. Values are expressed as mean ± SEM. The T3 serum concentration of rats acutely-treated with 100 g T3 per 100 g BW was not included in the statistics. * P < 0.0001 vs. SO and SO + T3. ** P < 0.0001 vs. SO and SO + T3. # P < 0.0001 vs. SO.
Evaluation of the effectiveness of the treatments
The effectiveness of the treatments was evaluated by determining the total serum T3 and TSH concentrations, body weight (BW), ventricular weight (VW), and the ratio between them. T3 was measured by RIA, using a standard curve prepared by adding different concentrations of T3 in iodothyronine-free rat serum, and the TSH, by a chemiluminescence immunoassay using Luminex xMAP technology (LINCOplex kit; Luminex Corp., Austin, TX, USA), as described (da Silva et al., 2010) . Intra and interassay coefficient of variation (% CV) for the TSH were <10%, and <5%, respectively. The minimum detectable concentration of TSH was 7.4 pg/ml. The antibody pair used in this assay is specific, and does not significantly cross-react with each other. The recovery (%) of TSH in serum matrices was 79%, and the accuracy of the assay was 113.2%.
Statistical analysis
The data were expressed as mean values ± SEM and subjected to ANOVA, followed by the Student-Newman-Keuls test. Data were analyzed by Student's t-test, when appropriate. Differences were considered significant at P < 0.05.
Results
Characterization of the treatment effectiveness
The treatment effectiveness was confirmed by the data presented in Table 2 , which show a reduction in serum T3 concentration, BW, VW, VW/BW ratio, and an increased serum TSH concentration in the hypothyroid compared with sham-operated rats. The acute T3 administration to hypothyroid and euthyroid rats led to an increase in serum T3 levels, and did not change the serum TSH concentration nor the other parameters studied, as expected, since they require longer period of T3 treatment to be affected.
Thyroid hormone regulates the TSHˇmRNA poly(A) tail length
The size of TSH␤ mRNA poly(A) tail, which directly correlates with transcript stability, was shown to be increased in pituitaries of hypothyroid compared with sham-operated rats (Fig. 1) . This effect was completely reversed after acute (30 min) T3 administration. T3 administration also reduced TSH␤ mRNA poly(A) tail of shamoperated rats, however this alteration was not significant (Fig. 1). 
Thyroid hormone regulates the TSHˇmRNA binding to the translational machinery
The translation rate of TSH␤ transcripts was indirectly evaluated by the amount of TSH␤ transcripts recruited to translational machinery, which was shown to be increased in pituitaries of hypothyroid (Fig. 2B ) compared with sham-operated rats (Fig. 2A) .
The acute T3 administration to hypothyroid rats rapidly decreased the amount of TSH␤ transcript attached to the polysomal fraction compared with hypothyroid rats, as shown in Fig. 3A and B. On the other hand, in the sham-operated rats the same T3 treatment schedule led to an increase on the TSH␤ mRNA content in the polysomal fraction vs. sham-operated rats (Fig. 4A and B) . Thus, it was observed that acute T3 treatment provokes a completely different response according to the thyroid state of the animals.
The histograms in Figs. 2C, 3C and 4C illustrate the quantitative representation (means ± SEM) obtained by densitometric analysis, in arbitrary units, for each treatment condition. Fig. 1 . T3 rapidly decreases the TSH␤ mRNA poly(A) tail length in pituitaries of hypothyroid rats. The analysis of TSH␤ mRNA poly(A) tail length was carried out by rapid amplification of cDNA ends for poly(A) test (RACE-PAT) in pituitaries of sham-operated rats treated with saline (SO) or 100 g T3/100 g BW iv (SO + T3) and hypothyroid rats treated with saline (Tx) or 100 g T3/100 g BW iv (Tx + T3). The smearing pattern of PCR products in ethidium bromide-stained 2.5% agarose gel obtained by RACE PAT is shown at the top. The horizontal line delimits the heaviest PCR fragments generated in the samples of the groups specified above. The maximal size of the amplicons, corresponding to the top of the smear of each sample, (in base pairs [bp] ), is shown at the bottom. Data are expressed as mean ± SEM of 5 independent experiments. At least four animals per group were used in each experiment. *P < 0.05 vs. all groups.
Fig. 2.
Hypothyroidism increases TSH␤ mRNA content attached to ribosome in rats' pituitaries. Panels A and B illustrate the polysome profile of TSH␤ mRNA in pituitaries of sham-operated (SO) and hypothyroid (Tx) rats, evaluated by Northern blotting, respectively. The ribosome subunits are indicated on the polysome profile as 40S and 60S peaks followed by the 80S monosome and polysome peaks. Panel C illustrates the quantitative representation obtained by densitometric analysis of TSH␤ and 18S transcripts hybridization ratio in arbitrary units, in which SO group was normalized to 1. Ten pituitaries were used per experiment, and a total of 7 experiments were performed. Data are expressed as mean ± SEM in arbitrary units and analyzed by Student's t-test. *P < 0.001 vs. SO.
Thyroid hormone regulates the TSHˇmRNA binding to cytoskeleton
The transcripts binding to cytoskeleton is a parameter that positively correlates with mRNA stability and translation rate. It was observed that the TSH␤ transcripts content associated to F-actin fraction was increased in pituitaries of hypothyroid rats, and that the acute (30 min) T3 treatment did not induce any change in the TSH␤ mRNA amount bound to cytoskeleton, as shown in Fig. 5 . The same occurred when sham-operated animals were acutely treated with T3 (Fig. 5) .
Discussion
In the present study we investigated the role of thyroid hormone on the posttranscriptional regulation of TSH␤ gene expression, mainly by evaluating the effects of hypothyroidism followed or not by the acute T3 treatment on the control of the stability and translation rate of TSH␤ mRNA. Both processes constitute important mechanism involved in the control of the gene expression, which could be promptly modulated, leading to rapid modifications on TSH synthesis.
We have shown that, in parallel to the recognized increase in the TSH␤ gene transcription observed in hypothyroid rats (Shupnik and Ridgway, 1987) , the TSH␤ mRNA processing is also altered, as indicated by the increase of TSH␤ mRNA poly(A) tail length, which plays fundamental roles in mRNA decay and translation (Viphakone et al., 2008) . Hence, this finding strongly points out to an improvement of the transcript stability and translation, which might contribute for the high TSH synthesis and secretion, observed in this condition.
The role of T3 on TSH␤ transcript stability became more evident after hypothyroid rats had been acutely treated with T3, when a rapid shortening of the TSH␤ mRNA poly(A) tail length occurred, which is in concordance with Krane et al. (1991) studies. However, it is worth mentioning that Krane's study was performed in dispersed rat pituitary cultures maintained in hypothyroid medium, in which T3 effects inducing a shortening of the TSH␤ mRNA poly(A) tail length were observed only 8 h after the treatment. In this long period of time, we cannot discard the possibility that T3 might act at transcriptional level modulating the synthesis of some protein related to poly(A) tail length of TSH␤ transcript. In the present study we have shown a rapid effect of T3 on the TSH␤ transcript poly(A) tail shortening, which was established 30 min after hypothyroid rats have been treated with the hormone. Given the novelty of the data here presented we might infer that T3 effect on the control of TSH␤ mRNA polyadenylation was supposedly nongenomic.
Although, the mechanism that underlies this effect is still unidentified, there is a possibility that proteins capable to inter- Fig. 3 . T3 acutely decreases TSH␤ mRNA content attached to ribosome in pituitaries of hypothyroid rats. Panels A and B illustrate the polysome profile of TSH␤ mRNA in pituitaries of hypothyroid (Tx) and hypothyroid (Tx + T3) rats acutely treated with T3 (100 g/100 g BW iv), evaluated by Northern blotting, respectively. The ribosome subunits are indicated on the polysome profile as 40S and 60S peaks followed by the 80S monosome and polysome peaks. Panel C illustrates the quantitative representation obtained by densitometric analysis of TSH␤ and 18S transcripts hybridization ratio in arbitrary units, in which Tx group was normalized to 1. Ten pituitaries were used per experiment, and a total of 7 experiments were performed. Data represent mean ± SEM expressed in arbitrary units and analyzed by Student's t-test. *P < 0.01 vs. Tx. Fig. 4 . T3 acutely increases TSH␤ mRNA content attached to ribosome in pituitaries of sham-operated rats. Panels A and B illustrate the polysome profile of TSH␤ mRNA in pituitaries of sham-operated (SO) and sham-operated (SO + T3) rats acutely treated with T3 (100 g/100 g BW iv), evaluated by Northern blotting, respectively. The ribosome subunits are indicated on the polysome profile as 40S and 60S peaks followed by the 80S monosome and polysome peaks. Panel C illustrates the quantitative representation obtained by densitometric analysis of TSH␤ and 18S transcripts hybridization ratio in arbitrary units, in which SO group was normalized to 1. Ten pituitaries were used per experiment, and a total of 3 experiments were performed. Data represent mean ± SEM expressed in arbitrary units and analyzed by Student's t-test. *P < 0.01 vs. SO. Fig. 5 . Hypothyroidism increases TSH␤ mRNA content bound to cytoskeleton in rats' pituitaries. This study evaluated the TSH␤ mRNA content bound to actin cytoskeleton in pituitaries of sham-operated rats treated with saline (SO) or 100 g T3/100 g BW iv (SO + T3) and hypothyroid rats treated with saline (Tx) or 100 g T3/100 g BW iv (Tx + T3). Two experiments were performed with 4 animals per group (N = 8). The TSH␤ mRNA expression was determined by real time PCR and values obtained were normalized by RPL19 mRNA expression. *P < 0.0001 vs. SO and SO + T3 (SO vs. Tx); # P < 0.0001 vs. SO and SO + T3. act with the transcripts might be involved on it, decreasing their half-lives. Indeed, a cytoplasmic trans-acting factor of approximately 80-85 kDa was identified from rat pituitaries and several cell lines, that binds in a sequence-specific manner to the 3 -UTR of rat TSH␤ mRNA, and it was shown that the binding activity of this factor is positively regulated by T3 (Leedman et al., 1995) .
In contrast, the sham-operated rats acutely treated with T3 did not present any change on TSH␤ mRNA poly(A) tail length, which indicates that transcript stability is not altered by T3 under euthyroid conditions.
The stability of mRNAs is an important condition for determining appropriate protein synthesis, since stable transcripts are less susceptible to degradation, which in turn leads to an increase in the pool of mRNA to be translated. In fact, in the hypothyroid rats, we have shown an increase in TSH␤ transcripts poly(A) tail length, which points out that their stability is increased. We have also observed in this condition that TSH␤ mRNA bound to ribosomes is increased, which strongly indicate that protein synthesis is being stimulated.
Although it is known that the TSH␤ gene transcription rate is increased in hypothyroid states, leading to an increased TSH protein synthesis, our findings show that the increase on poly(A) tail length might contribute to the transcripts recruitment to translational machinery.
As discussed above, thyroid hormones down-regulate the TSH gene expression by genomic mechanisms, which involve many steps and, therefore, require more time to be established. However, our data showing that 30 min after T3 treatment, the hypothyroid rats presented a significant reduction in the TSH␤ transcripts recruited to ribosomes, describe a novel and rapid mechanism of thyroid hormone action on the thyrotrophs, which seems to be uncoupled of its inhibitory effects on TSH␤ gene transcription. In fact, the decreasing of poly(A) tail length induced by acute T3 treatment might help to understand, at least in part, the minor association between TSH␤ transcripts and ribosomes, since the translational efficiency is regulated by the poly(A) tail length and the poly(A)-binding protein (PABP). PABP, after binding to the poly(A) tail, interacts with translational initiation factors leading to the anchoring of transcripts to ribosomes. Therefore, transcripts with shorter poly(A) tail will have a reduced association to the translational machinery, impairing the protein synthesis (Wang et al., 1999) .
However, the sham-operated rats did not respond to acute T3 treatment like hypothyroid rats did. In these rats we have shown that 30 min after T3 administration, there was an increase of TSH␤ transcripts bound to ribosomes, which was an unexpected finding. We suppose that in an euthyroid condition, in which TSH␤ transcript is being normally recruited to ribosomes, the abrupt supply of T3 might disturb the translation process at the step of peptide chain elongation or termination or both, as indicated by the increased proportion of TSH␤ transcripts in large polysomes (Kawaguchi et al., 2003) . The fact that the poly(A) tail length of TSH␤ transcript was not modified by T3 treatment might account for this assumption.
It is known that the mRNA association to cytoskeleton is important for its stability and translation efficiency (Shannon et al., 1998; Hovland et al., 1996) . Thus the increased binding of TSH␤ mRNA on cytoskeleton of hypothyroid rats' pituitaries is a finding that reinforces the data obtained in the present study. However, the TSH␤ transcript binding to cytoskeleton was not altered by acute T3 administration, which suggests that T3 effects inducing decreased stability and recruitment of TSH␤ transcripts to ribosome are dissociated of cytoskeleton activity, a finding that differs from the data observed in somatotrophs (da Silva et al., 2010) , indicating that it might be cell specific.
Conclusion
In summary, in parallel to its transcriptional action decreasing TSH␤ gene expression, thyroid hormone also down-regulates TSH␤ gene expression at posttranscriptional level, as pointed by the increased TSH␤ transcript stability and translation rate in hypothyroid rats, and the rapid reversion of these findings by acute T3 administration. These findings indicate a rapid regulation of TSH␤ transcript processing by T3, an effect which is more remarkable in the hypothyroid condition.
Considering that posttranscriptional processes are rapidly settled, we assume that T3 acutely administered might act through these mechanisms reducing the TSH output, before transcriptional mechanisms are elicited, ensuring a prompt reduction of TSH synthesis and release, through a very short negative feedback loop.
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